vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and H2O AMERICA (HTO). Click either name above to swap in a different company.
H2O AMERICA is the larger business by last-quarter revenue ($199.4M vs $180.9M, roughly 1.1× AVANOS MEDICAL, INC.). H2O AMERICA runs the higher net margin — 8.1% vs -0.7%, a 8.9% gap on every dollar of revenue. On growth, H2O AMERICA posted the faster year-over-year revenue change (1.5% vs 0.7%). Over the past eight quarters, H2O AMERICA's revenue compounded faster (15.3% CAGR vs 4.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
H2O Wireless is a United States-based prepaid cell phone service, that utilizes the AT&T network. It is a brand of the mobile virtual network operator (MVNO) Locus Telecommunications, a subsidiary of Telrite Holdings, Inc., since 2019. Locus was formerly a subsidiary of KDDI America corporation, starting in 2010. H2O Wireless is primarily advertised as a non-restrictive phone service for customers to bring or buy unlocked smartphones, although AT&T contract/locked phones may be accepted as well.
AVNS vs HTO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $199.4M |
| Net Profit | $-1.3M | $16.2M |
| Gross Margin | 47.5% | — |
| Operating Margin | 1.4% | 16.6% |
| Net Margin | -0.7% | 8.1% |
| Revenue YoY | 0.7% | 1.5% |
| Net Profit YoY | 99.7% | -29.2% |
| EPS (diluted) | $-0.02 | $0.45 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $199.4M | ||
| Q3 25 | $177.8M | $243.5M | ||
| Q2 25 | $175.0M | $197.8M | ||
| Q1 25 | $167.5M | $164.9M | ||
| Q4 24 | $179.6M | $196.5M | ||
| Q3 24 | $170.4M | $216.7M | ||
| Q2 24 | $171.7M | $173.1M | ||
| Q1 24 | $166.1M | $150.0M |
| Q4 25 | $-1.3M | $16.2M | ||
| Q3 25 | $-1.4M | $45.1M | ||
| Q2 25 | $-76.8M | $24.7M | ||
| Q1 25 | $6.6M | $16.6M | ||
| Q4 24 | $-397.3M | $22.9M | ||
| Q3 24 | $4.3M | $38.7M | ||
| Q2 24 | $1.8M | $20.7M | ||
| Q1 24 | $-900.0K | $11.7M |
| Q4 25 | 47.5% | — | ||
| Q3 25 | 48.4% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.6% | — | ||
| Q4 24 | 54.6% | — | ||
| Q3 24 | 54.5% | — | ||
| Q2 24 | 55.7% | — | ||
| Q1 24 | 57.1% | — |
| Q4 25 | 1.4% | 16.6% | ||
| Q3 25 | 0.1% | 26.5% | ||
| Q2 25 | -42.6% | 22.2% | ||
| Q1 25 | 6.1% | 21.8% | ||
| Q4 24 | -233.0% | 22.2% | ||
| Q3 24 | 7.0% | 26.9% | ||
| Q2 24 | 3.7% | 23.4% | ||
| Q1 24 | 2.4% | 18.6% |
| Q4 25 | -0.7% | 8.1% | ||
| Q3 25 | -0.8% | 18.5% | ||
| Q2 25 | -43.9% | 12.5% | ||
| Q1 25 | 3.9% | 10.0% | ||
| Q4 24 | -221.2% | 11.7% | ||
| Q3 24 | 2.5% | 17.8% | ||
| Q2 24 | 1.0% | 12.0% | ||
| Q1 24 | -0.5% | 7.8% |
| Q4 25 | $-0.02 | $0.45 | ||
| Q3 25 | $-0.03 | $1.27 | ||
| Q2 25 | $-1.66 | $0.71 | ||
| Q1 25 | $0.14 | $0.49 | ||
| Q4 24 | $-8.64 | $0.70 | ||
| Q3 24 | $0.09 | $1.17 | ||
| Q2 24 | $0.04 | $0.64 | ||
| Q1 24 | $-0.02 | $0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $20.7M |
| Total DebtLower is stronger | $90.3M | $1.9B |
| Stockholders' EquityBook value | $778.2M | $1.5B |
| Total Assets | $1.1B | $5.1B |
| Debt / EquityLower = less leverage | 0.12× | 1.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $20.7M | ||
| Q3 25 | $70.5M | $11.3M | ||
| Q2 25 | $90.3M | $19.8M | ||
| Q1 25 | $97.0M | $23.7M | ||
| Q4 24 | $107.7M | $11.1M | ||
| Q3 24 | $89.0M | $4.0M | ||
| Q2 24 | $92.2M | $22.8M | ||
| Q1 24 | $75.8M | $4.5M |
| Q4 25 | $90.3M | $1.9B | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | $1.7B | ||
| Q3 24 | $152.6M | — | ||
| Q2 24 | $164.9M | — | ||
| Q1 24 | $167.2M | — |
| Q4 25 | $778.2M | $1.5B | ||
| Q3 25 | $778.0M | $1.5B | ||
| Q2 25 | $776.3M | $1.5B | ||
| Q1 25 | $839.4M | $1.4B | ||
| Q4 24 | $828.5M | $1.4B | ||
| Q3 24 | $1.2B | $1.3B | ||
| Q2 24 | $1.2B | $1.3B | ||
| Q1 24 | $1.2B | $1.2B |
| Q4 25 | $1.1B | $5.1B | ||
| Q3 25 | $1.1B | $5.0B | ||
| Q2 25 | $1.0B | $4.8B | ||
| Q1 25 | $1.1B | $4.7B | ||
| Q4 24 | $1.2B | $4.7B | ||
| Q3 24 | $1.7B | $4.6B | ||
| Q2 24 | $1.7B | $4.4B | ||
| Q1 24 | $1.7B | $4.4B |
| Q4 25 | 0.12× | 1.23× | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | 1.26× | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $63.5M |
| Free Cash FlowOCF − Capex | $21.3M | — |
| FCF MarginFCF / Revenue | 11.8% | — |
| Capex IntensityCapex / Revenue | 3.8% | — |
| Cash ConversionOCF / Net Profit | — | 3.92× |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $63.5M | ||
| Q3 25 | $14.0M | $77.3M | ||
| Q2 25 | $6.8M | $60.8M | ||
| Q1 25 | $25.7M | $43.2M | ||
| Q4 24 | $57.9M | $41.5M | ||
| Q3 24 | $23.0M | $53.5M | ||
| Q2 24 | $27.8M | $49.3M | ||
| Q1 24 | $-8.0M | $51.2M |
| Q4 25 | $21.3M | — | ||
| Q3 25 | $7.0M | — | ||
| Q2 25 | $-4.2M | — | ||
| Q1 25 | $19.0M | — | ||
| Q4 24 | $53.1M | — | ||
| Q3 24 | $20.0M | — | ||
| Q2 24 | $21.9M | — | ||
| Q1 24 | $-12.1M | — |
| Q4 25 | 11.8% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | -2.4% | — | ||
| Q1 25 | 11.3% | — | ||
| Q4 24 | 29.6% | — | ||
| Q3 24 | 11.7% | — | ||
| Q2 24 | 12.8% | — | ||
| Q1 24 | -7.3% | — |
| Q4 25 | 3.8% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | 3.4% | — | ||
| Q1 24 | 2.5% | — |
| Q4 25 | — | 3.92× | ||
| Q3 25 | — | 1.71× | ||
| Q2 25 | — | 2.47× | ||
| Q1 25 | 3.89× | 2.61× | ||
| Q4 24 | — | 1.81× | ||
| Q3 24 | 5.35× | 1.39× | ||
| Q2 24 | 15.44× | 2.38× | ||
| Q1 24 | — | 4.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
HTO
| Water Utility Services | $191.0M | 96% |
| Other | $8.4M | 4% |
